Cepheid
Sunnyvale, CA 94089
Share:
Cepheid Receives CE-IVD Clearance for Xpert HCV VL Fingerstick
Enables Hepatitis C Point-of-Care molecular testing and linkage to care SUNNYVALE, Calif., Sept. 19, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA levels directly from a fingerstick blood sample. Currently, the clinical care pathway for detection of hepatitis C faces many...
Read More »Cepheid Receives CE-IVD Clearance for Xpert HCV VL Fingerstick
Enables Hepatitis C Point-of-Care molecular testing and linkage to care SUNNYVALE, Calif., Sept. 19, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA levels directly from a fingerstick blood sample. Currently, the clinical care pathway for detection of hepatitis C faces many...
Read More »Molecular Diagnostic System features portable design.
At 9 in. tall and weighing just 2.2 lb, GeneXpert-® Omni meets needs of Point of Care market. System runs PCR-based Xpert® cartridges, enabling accurate clinical molecular diagnostic tests to be performed in any near-patient testing environment, including CLIA-waived physician offices, clinics and specialty settings. Wireless and web-enabled, system transmits instrument and test...
Read More »Molecular Diagnostic System features portable design.
At 9 in. tall and weighing just 2.2 lb, GeneXpertÃ-® Omniàmeets needs of Point of Care market. System runs PCR-based Xpertî cartridges, enabling accurate clinical molecular diagnostic tests to be performed in any near-patient testing environment, including CLIA-waived physician offices, clinics and specialty settings. Wireless and web-enabled, system transmitsàinstrument...
Read More »On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge
SUNNYVALE, Calif.- — Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating the global shipment of the 10 millionth Xpert MTB/RIF cartridge -- which was received by Helen Joseph Hospital Laboratory in Johannesburg, South Africa. The Xpert MTB/RIF test runs on Cepheid's GeneXpert® System, the world's...
Read More »On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge
SUNNYVALE, Calif.Ã- — Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating the global shipment of the 10 millionth Xpert MTB/RIF cartridge -- which was received by Helen Joseph Hospital Laboratory in Johannesburg, South Africa. The Xpert MTB/RIF test runs on Cepheid's GeneXpertî System, the...
Read More »Diagnostic Test System automates molecular analysis.
Offering fully automated random access system, GeneXpert Infinity-48 manages entire molecular testing workflow, including sample data, cartridge loading and unloading, and reporting of test results. System uses robotic cartridge handling, managed by Xpertise(TM) software package and full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period. System can...
Read More »Diagnostic Test System automates molecular analysis.
Offering fully automated random access system, GeneXpert Infinity-48 manages entire molecular testing workflow, including sample data, cartridge loading and unloading, and reporting of test results. System uses robotic cartridge handling, managed by Xpertise(TM) software package and full touch screen driven menu, to run up to 1,300 different molecular tests during any 24-hour period. System can...
Read More »Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL® FII & FV Assay to European Clinical Testing Market
New GeneXpert-®-Based Test to Assess Genetic Risk of Thrombosis Improves Time to Result and Eliminates Delays Associated with Batch Processing SUNNYVALE, Calif., and LEXINGTON, Mass., Feb. 25-- Cepheid (NASDAQ:CPHD) and Instrumentation Laboratory (IL), a leading clinical diagnostics company, today announced the release of the Xpert(TM) HemosIL® FII & FV assay as a European CE IVD Mark product...
Read More »Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL-® FII & FV Assay to European Clinical Testing Market
New GeneXpertÃ-®-Based Test to Assess Genetic Risk of Thrombosis Improves Time to Result and Eliminates Delays Associated with Batch Processing SUNNYVALE, Calif., and LEXINGTON, Mass., Feb. 25-- Cepheid (NASDAQ:CPHD) and Instrumentation Laboratory (IL), a leading clinical diagnostics company, today announced the release of the Xpert(TM) HemosILî FII & FV assay as a European CE IVD Mark...
Read More »Cepheid Receives CE-IVD Clearance for Xpert HCV VL Fingerstick
Enables Hepatitis C Point-of-Care molecular testing and linkage to care SUNNYVALE, Calif., Sept. 19, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA levels directly from a fingerstick blood sample. Currently, the clinical care pathway for detection of hepatitis C faces many...
Read More »Cepheid Receives CE-IVD Clearance for Xpert HCV VL Fingerstick
Enables Hepatitis C Point-of-Care molecular testing and linkage to care SUNNYVALE, Calif., Sept. 19, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to detect and quantify hepatitis C Virus (HCV) RNA levels directly from a fingerstick blood sample. Currently, the clinical care pathway for detection of hepatitis C faces many...
Read More »Molecular Diagnostic System features portable design.
At 9 in. tall and weighing just 2.2 lb, GeneXpert-® Omni meets needs of Point of Care market. System runs PCR-based Xpert® cartridges, enabling accurate clinical molecular diagnostic tests to be performed in any near-patient testing environment, including CLIA-waived physician offices, clinics and specialty settings. Wireless and web-enabled, system transmits instrument and test...
Read More »Molecular Diagnostic System features portable design.
At 9 in. tall and weighing just 2.2 lb, GeneXpertÃ-® Omniàmeets needs of Point of Care market. System runs PCR-based Xpertî cartridges, enabling accurate clinical molecular diagnostic tests to be performed in any near-patient testing environment, including CLIA-waived physician offices, clinics and specialty settings. Wireless and web-enabled, system transmitsàinstrument...
Read More »On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge
SUNNYVALE, Calif.- — Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating the global shipment of the 10 millionth Xpert MTB/RIF cartridge -- which was received by Helen Joseph Hospital Laboratory in Johannesburg, South Africa. The Xpert MTB/RIF test runs on Cepheid's GeneXpert® System, the world's...
Read More »On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge
SUNNYVALE, Calif.Ã- — Cepheid (Nasdaq: CPHD) and the National Health Laboratory Service (NHLS) in South Africa today recognized World TB Day 2015 by commemorating the global shipment of the 10 millionth Xpert MTB/RIF cartridge -- which was received by Helen Joseph Hospital Laboratory in Johannesburg, South Africa. The Xpert MTB/RIF test runs on Cepheid's GeneXpertî System, the...
Read More »Cepheid to Webcast Upcoming Financial Presentation
SUNNYVALE, Calif., Dec. 23, 2010 - Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast. J. P. Morgan Healthcare Conference Thursday, January 13, 2011 at 11.00 a.m. Pacific Time To access the live webcast for this event, please visit Cepheid's website at www.cepheid.com/investors at least...
Read More »Cepheid to Webcast Upcoming Financial Presentation
SUNNYVALE, Calif., Dec. 23, 2010 - Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast. J. P. Morgan Healthcare Conference Thursday, January 13, 2011 at 11.00 a.m. Pacific Time To access the live webcast for this event, please visit Cepheid's website at www.cepheid.com/investors at least...
Read More »Cepheid to Webcast Upcoming Financial Presentations
SUNNYVALE, Calif., Aug. 31 - Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast. Baird Health Care Conference, New York, NY Wednesday, September 15, 2010 at 10.30 a.m. Eastern Time Stifel Nicolaus Healthcare Conference, Boston, MA Thursday, September 16, 2010 at 10.55 a.m. Eastern Time...
Read More »Cepheid to Webcast Upcoming Financial Presentations
SUNNYVALE, Calif., Aug. 31 - Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast. Baird Health Care Conference, New York, NY Wednesday, September 15, 2010 at 10.30 a.m. Eastern Time Stifel Nicolaus Healthcare Conference, Boston, MA Thursday, September 16, 2010 at 10.55 a.m. Eastern Time...
Read More »